KYMERA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$126.63
+3.29%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+15.0%
3 months
+26.2%
6 months
+56.9%
1 year
+106.1%
Year to date
+62.7%
52-week range
$58.66 – $127.31
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$10.81B
P/E
-30.9
P/B
6.7
P/S
105.7
Revenue
$102.24M
Net income
-$349.43M
Diluted EPS
-3.63
Gross margin
100.00%
Net margin
-341.80%
Return on equity
-22.40%
Total debt
$76.6M
Cash
$379.58M
Free cash flow
-$288.89M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $0 | -$132M | — | — | -$78.23M |
| Jun 30, 2026 | $65M | -$61.21M | 100.00% | -94.20% | -$54.54M |
| Mar 31, 2026 | $34.37M | -$69.23M | 100.00% | -201.50% | -$89.27M |
| Dec 31, 2025 | $2.87M | -$86.98M | 100.00% | -3030.70% | -$66.85M |
| Sep 30, 2025 | $2.76M | -$82.18M | 100.00% | -2973.00% | -$27.29M |
| Jun 30, 2025 | $11.48M | -$76.61M | 100.00% | -667.60% | -$60.58M |
| Mar 31, 2025 | $22.1M | -$65.58M | 100.00% | -296.70% | -$79.62M |
| Dec 31, 2024 | $7.39M | -$70.75M | 100.00% | -956.90% | -$62.72M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent KYMR news
All market newsNo ticker-linked stories are in the current archive.